134 related articles for article (PubMed ID: 24361000)
1. Synthesis and anti-proliferative activity of aromatic substituted 5-((1-benzyl-1H-indol-3-yl)methylene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione analogs against human tumor cell lines.
Madadi NR; Penthala NR; Janganati V; Crooks PA
Bioorg Med Chem Lett; 2014 Jan; 24(2):601-3. PubMed ID: 24361000
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro screening of novel N-benzyl aplysinopsin analogs as potential anticancer agents.
Penthala NR; Yerramreddy TR; Crooks PA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1411-3. PubMed ID: 21295476
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
4. Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents.
Reddy YT; Sekhar KR; Sasi N; Reddy PN; Freeman ML; Crooks PA
Bioorg Med Chem Lett; 2010 Jan; 20(2):600-2. PubMed ID: 20005706
[TBL] [Abstract][Full Text] [Related]
5. 1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).
Penthala NR; Ketkar A; Sekhar KR; Freeman ML; Eoff RL; Balusu R; Crooks PA
Bioorg Med Chem; 2015 Nov; 23(22):7226-33. PubMed ID: 26602084
[TBL] [Abstract][Full Text] [Related]
6. Microwave assisted synthesis and in vitro cytotoxicities of substituted (Z)-2-amino-5-(1-benzyl-1H-indol-3-yl)methylene-1-methyl-1H-imidazol-4(5H)-ones against human tumor cell lines.
Penthala NR; Yerramreddy TR; Crooks PA
Bioorg Med Chem Lett; 2010 Jan; 20(2):591-3. PubMed ID: 20006496
[TBL] [Abstract][Full Text] [Related]
7. 5-((1-Aroyl-1H-indol-3-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-diones as potential anticancer agents with anti-inflammatory properties.
Penthala NR; Ponugoti PR; Kasam V; Crooks PA
Bioorg Med Chem Lett; 2013 Mar; 23(5):1442-6. PubMed ID: 23339966
[TBL] [Abstract][Full Text] [Related]
8. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
9. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective Synthesis of the Di-Spirooxindole Analogs Based Oxindole and Cyclohexanone Moieties as Potential Anticancer Agents.
Al-Majid AM; Ali M; Islam MS; Alshahrani S; Alamary AS; Yousuf S; Choudhary MI; Barakat A
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684885
[TBL] [Abstract][Full Text] [Related]
11. Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
Bommagani S; Ponder J; Penthala NR; Janganati V; Jordan CT; Borrelli MJ; Crooks PA
Eur J Med Chem; 2017 Aug; 136():393-405. PubMed ID: 28525840
[TBL] [Abstract][Full Text] [Related]
12. Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted (Z)-5-(N-benzylindol-3-ylmethylene)imidazolidine-2,4-diones.
Thirupathi Reddy Y; Narsimha Reddy P; Koduru S; Damodaran C; Crooks PA
Bioorg Med Chem; 2010 May; 18(10):3570-4. PubMed ID: 20403701
[TBL] [Abstract][Full Text] [Related]
13. 2-Amino-4-methyl-5-phenylethyl substituted-7-N-benzyl-pyrrolo[2,3-d]pyrimidines as novel antitumor antimitotic agents that also reverse tumor resistance.
Gangjee A; Namjoshi OA; Keller SN; Smith CD
Bioorg Med Chem; 2011 Jul; 19(14):4355-65. PubMed ID: 21680190
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel substituted pyrimidine derivatives bearing a sulfamide group and their in vitro cancer growth inhibition activity.
Lefebvre CA; Forcellini E; Boutin S; Côté MF; C-Gaudreault R; Mathieu P; Lagüe P; Paquin JF
Bioorg Med Chem Lett; 2017 Jan; 27(2):299-302. PubMed ID: 27903409
[TBL] [Abstract][Full Text] [Related]
17. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines.
Ranjan Dwivedi A; Kumar V; Kaur H; Kumar N; Prakash Yadav R; Poduri R; Baranwal S; Kumar V
Bioorg Med Chem Lett; 2020 Oct; 30(20):127468. PubMed ID: 32768647
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of (Z)-2,3-diphenylacrylonitrile analogs as anti-cancer and anti-microbial agents.
Alam MS; Nam YJ; Lee DU
Eur J Med Chem; 2013 Nov; 69():790-7. PubMed ID: 24113364
[TBL] [Abstract][Full Text] [Related]
20. Indole-Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents-Synthesis, In Vitro and In Silico Studies.
Kornicka A; Gzella K; Garbacz K; Jarosiewicz M; Gdaniec M; Fedorowicz J; Balewski Ł; Kokoszka J; Ordyszewska A
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]